United States Surgical Heart Valves Market Outlook to 2036 - Cardiac Valve Repair Devices and Prosthetic Heart Valves

1.1 What Is This Report About?
1.2 Surgical Heart Valves Market Segmentation
1.3 Definitions of Markets Covered in the Report

2.1 Surgical Heart Valves Market, North America, Revenue ($m), 2024-2036
2.2 Surgical Heart Valves Market, North America, Revenue ($m), 2024-2036
2.3 Surgical Heart Valves Market, North America, Volume (Units), 2024-2036
2.4 Surgical Heart Valves Market, North America, Volume (Units), 2024-2036
2.5 Surgical Heart Valves Market, North America, Company Share by Revenue ($m), 2025

3.1 Surgical Heart Valves Market, Canada, Revenue ($m), 2024-2036
3.1.1 Cardiac Valve Repair Devices Market, Canada, Revenue ($m), by Segment, 2024-2036
3.1.2 Prosthetic Heart Valves Market, Canada, Revenue ($m), by Segment, 2024-2036
3.2 Surgical Heart Valves Market, Canada, Volume (Units), 2024-2036
3.2.1 Cardiac Valve Repair Devices Market, Canada, Volume (Units), by Segment, 2024-2036
3.2.2 Prosthetic Heart Valves Market, Canada, Volume (Units), by Segment, 2024-2036
3.3 Surgical Heart Valves Market, Canada, Average Price ($), 2024-2036
3.4 Surgical Heart Valves Market, Canada, Company Share by Revenue ($m), 2025

4.1 Surgical Heart Valves Market, Mexico, Revenue ($m), 2024-2036
4.1.1 Cardiac Valve Repair Devices Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.1.2 Prosthetic Heart Valves Market, Mexico, Revenue ($m), by Segment, 2024-2036
4.2 Surgical Heart Valves Market, Mexico, Volume (Units), 2024-2036
4.2.1 Cardiac Valve Repair Devices Market, Mexico, Volume (Units), by Segment, 2024-2036
4.2.2 Prosthetic Heart Valves Market, Mexico, Volume (Units), by Segment, 2024-2036
4.3 Surgical Heart Valves Market, Mexico, Average Price ($), 2024-2036
4.4 Surgical Heart Valves Market, Mexico, Company Share by Revenue ($m), 2025

5.1 Surgical Heart Valves Market, United States, Revenue ($m), 2024-2036
5.1.1 Cardiac Valve Repair Devices Market, United States, Revenue ($m), by Segment, 2024-2036
5.1.2 Prosthetic Heart Valves Market, United States, Revenue ($m), by Segment, 2024-2036
5.2 Surgical Heart Valves Market, United States, Volume (Units), 2024-2036
5.2.1 Cardiac Valve Repair Devices Market, United States, Volume (Units), by Segment, 2024-2036
5.2.2 Prosthetic Heart Valves Market, United States, Volume (Units), by Segment, 2024-2036
5.3 Surgical Heart Valves Market, United States, Average Price ($), 2024-2036
5.4 Surgical Heart Valves Market, United States, Company Share by Revenue ($m), 2025

6.1 Surgical Heart Valves Market Pipeline Products
6.2 Surgical Heart Valves - Pipeline Products by Stage of Development
6.3 Surgical Heart Valves - Pipeline Products by Segment
6.4 Surgical Heart Valves - Pipeline Products by Territory
6.5 Surgical Heart Valves - Pipeline Products by Regulatory Path
6.6 Surgical Heart Valves - Pipeline Products by Estimated Approval Date

7.1 Edwards Lifesciences Corp
7.1.1 Company Overview
7.2 Abbott Laboratories
7.2.1 Company Overview
7.3 Artivion Inc
7.3.1 Company Overview
7.4 Medtronic Plc
7.4.1 Company Overview
7.5 Corcym UK Ltd
7.5.1 Company Overview

8.1 Corporate Communications
8.1.1 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
8.1.2 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.1.3 Nov 10, 2025: Dr. Felicitas Koller Named Inaugural Hardy-Raju Chair of Transplant Surgery
8.1.4 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
8.1.5 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager
8.1.6 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.1.7 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.1.8 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.1.9 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.1.10 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study
8.1.11 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System
8.1.12 Oct 15, 2025: Adagio Medical Prices $50 Million Private Placement of Securities
8.1.13 Oct 13, 2025: Tavr And Savr Removal With Left Ventricular Outflow Reconstruction
8.1.14 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.1.15 Sep 12, 2025: Cedars-Sinai Receives $26M to Research Heart Valve Disease
8.2 Financial Announcements
8.2.1 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.2.2 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.2.3 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.3 Government and Public Interest
8.3.1 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting
8.4 Other Significant Developments
8.4.1 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months
8.4.2 Nov 13, 2025: Catheter Precision Reports Third Quarter and First Nine Months 2025 Results
8.4.3 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.4.4 Nov 03, 2025: News Updates for Q3 2025
8.4.5 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.4.6 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
8.4.7 Oct 16, 2025: Excision Of A Six-Year-Old Evolut CoreValve TAVR
8.4.8 Oct 15, 2025: Adagio Medical Prices $50 Million Private Placement of Securities
8.4.9 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting
8.4.10 Oct 13, 2025: Tavr And Savr Removal With Left Ventricular Outflow Reconstruction
8.4.11 Sep 12, 2025: Cedars-Sinai Receives $26M to Research Heart Valve Disease
8.4.12 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
8.5 Product News
8.5.1 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV
8.5.2 Nov 20, 2025: Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Clinical Results
8.5.3 Nov 19, 2025: Canon Medical Systems USA Introduces Alphenix 4D CT with Aquilion ONE/INSIGHT Edition, Now FDA Cleared
8.5.4 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months
8.5.5 Nov 17, 2025: JenaValve Completes 1,000th Case with Trilogy Transcatheter Heart Valve System
8.5.6 Nov 13, 2025: EnVVeno Faces FDA Rejection on VenoValve Application
8.5.7 Nov 12, 2025: VitAA Medical Receives FDA Clearance for AiORTA Plan in Aortic Care
8.5.8 Nov 12, 2025: Adagio Medical Reports Third Quarter 2025 Results
8.5.9 Nov 07, 2025: Gore Announces Positive Clinical Trial Results of the Investigational Gore Viabahn Fortegra Venous Stent for Treatment of Patients with Deep Venous Iliocaval Obstruction
8.5.10 Nov 06, 2025: Artivion Treats First Patient in ARTIZEN Trial for Arcevo LSA
8.5.11 Nov 05, 2025: Pulse Biosciences Reports Business Updates and Third Quarter 2025 Financial Results
8.5.12 Nov 05, 2025: Fluid Control Solutions For MedTech
8.5.13 Nov 04, 2025: AVS Reports Positive Safety and Effectiveness Data from Pulse IVL IDE Study
8.5.14 Nov 04, 2025: Contego Medical Reports 30-Day Outcomes From PERFORMANCE III TCAR-IEP Study
8.5.15 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
8.5.16 Nov 03, 2025: Johnson & Johnson Confirms Durability of IVL in Complex Below-the-Knee Anatomy
8.5.17 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
8.5.18 Oct 30, 2025: Humacyte Publishes New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma
8.5.19 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
8.5.20 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
8.5.21 Oct 27, 2025: Successful Patient Outcomes With Edwards’ SAPIEN M3 and EVOQUE Systems
8.5.22 Oct 26, 2025: Jupiter Endovascular Reports Positive Results From SPIRARE I First-in-Human Study
8.5.23 Oct 24, 2025: Protaryx Medical Submits 510(k) Application for Next-Generation Transseptal Puncture Device
8.5.24 Oct 23, 2025: Cordis-X Advances FASTEN Trial for Ladera Large Bore Closure System
8.5.25 Oct 23, 2025: Emboline, Inc. Completes Enrollment in U.S. Pivotal IDE Trial of the Emboliner Embolic Protection Catheter
8.5.26 Oct 15, 2025: Adagio Medical Prices $50 Million Private Placement of Securities
8.5.27 Oct 07, 2025: Jupiter Endovascular Secures Over $40 Million in Series B Financing
8.5.28 Oct 01, 2025: Adagio Medical Completes Enrollment in FULCRUM-VT Clinical Trial for Ventricular Tachycardia
8.5.29 Sep 28, 2025: Acoramidis Reduces Cardiovascular Outcomes in ATTR-CM Patients Within the First Month
8.5.30 Sep 10, 2025: OEM Toll Processing Enhances High-Value Products
8.6 Strategy And Business Planning
8.6.1 Nov 09, 2025: Edwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve Disease
8.6.2 Nov 05, 2025: Microbot Medical Commences Limited Market Release of LIBERTY Endovascular Robotic System in the U.S.
8.6.3 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics
8.6.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research

9.1Research Methodology
9.1.1 Coverage
9.1.2 Secondary Research
9.1.3 Primary Research
9.1.4 Market Modeling and Forecasting
9.1.5 Company Share Analysis
9.1.6 Benchmarking
9.2 the analyst Consulting
9.3 Contact the Publisher
9.4 Disclaimer

Table 1: Surgical Heart Valves Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Table 2: Surgical Heart Valves Market, North America, Revenue ($m), USD Constant, 2024-2036
Table 3: Surgical Heart Valves Market, North America, Volume (Units), 2024-2036
Table 4: Surgical Heart Valves Market, North America, Volume (Units), 2024-2036
Table 5: Surgical Heart Valves Market, North America, Company Share by Revenue ($m), 2025
Table 6: Surgical Heart Valves Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 7: Cardiac Valve Repair Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 8: Prosthetic Heart Valves Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 9: Surgical Heart Valves Market, Canada, Volume (Units), 2024-2036
Table 10: Cardiac Valve Repair Devices Market, Canada, Volume (Units), 2024-2036
Table 11: Prosthetic Heart Valves Market, Canada, Volume (Units), 2024-2036
Table 12: Surgical Heart Valves Market, Canada, Average Price ($), 2024-2036
Table 13: Surgical Heart Valves Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 14: Surgical Heart Valves Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 15: Cardiac Valve Repair Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 16: Prosthetic Heart Valves Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Table 17: Surgical Heart Valves Market, Mexico, Volume (Units), 2024-2036
Table 18: Cardiac Valve Repair Devices Market, Mexico, Volume (Units), 2024-2036
Table 19: Prosthetic Heart Valves Market, Mexico, Volume (Units), 2024-2036
Table 20: Surgical Heart Valves Market, Mexico, Average Price ($), 2024-2036
Table 21: Surgical Heart Valves Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025
Table 22: Surgical Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 23: Cardiac Valve Repair Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 24: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 25: Surgical Heart Valves Market, United States, Volume (Units), 2024-2036
Table 26: Cardiac Valve Repair Devices Market, United States, Volume (Units), 2024-2036
Table 27: Prosthetic Heart Valves Market, United States, Volume (Units), 2024-2036
Table 28: Surgical Heart Valves Market, United States, Average Price ($), 2024-2036
Table 29: Surgical Heart Valves Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 30: Surgical Heart Valves Market Pipeline Products
Table 31: Surgical Heart Valves - Pipeline Products by Stage of Development
Table 32: Surgical Heart Valves Companies - Pipeline Products by Stage of Development
Table 33: Surgical Heart Valves - Pipeline Products by Segment
Table 34: Surgical Heart Valves - Pipeline Products by Territory
Table 35: Surgical Heart Valves - Pipeline Products by Regulatory Path
Table 36: Surgical Heart Valves - Pipeline Products by Estimated Approval Date
Table 37: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country

Figure 1: Surgical Heart Valves Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036
Figure 2: Surgical Heart Valves Market, North America, Revenue ($m), USD Constant, 2024-2036
Figure 3: Surgical Heart Valves Market, North America, Volume (Units), 2024-2036
Figure 4: Surgical Heart Valves Market, North America, Volume (Units), 2024-2036
Figure 5: Surgical Heart Valves Market, North America, Company Share (%), 2025
Figure 6: Surgical Heart Valves Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 7: Cardiac Valve Repair Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 8: Prosthetic Heart Valves Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 9: Surgical Heart Valves Market, Canada, Volume (Units), 2024-2036
Figure 10: Cardiac Valve Repair Devices Market, Canada, Volume (Units), 2024-2036
Figure 11: Prosthetic Heart Valves Market, Canada, Volume (Units), 2024-2036
Figure 12: Surgical Heart Valves Market, Canada, Company Share (%), 2025
Figure 13: Surgical Heart Valves Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 14: Cardiac Valve Repair Devices Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 15: Prosthetic Heart Valves Market, Mexico, Revenue ($m), USD Constant, 2024-2036
Figure 16: Surgical Heart Valves Market, Mexico, Volume (Units), 2024-2036
Figure 17: Cardiac Valve Repair Devices Market, Mexico, Volume (Units), 2024-2036
Figure 18: Prosthetic Heart Valves Market, Mexico, Volume (Units), 2024-2036
Figure 19: Surgical Heart Valves Market, Mexico, Company Share (%), 2025
Figure 20: Surgical Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 21: Cardiac Valve Repair Devices Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 22: Prosthetic Heart Valves Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 23: Surgical Heart Valves Market, United States, Volume (Units), 2024-2036
Figure 24: Cardiac Valve Repair Devices Market, United States, Volume (Units), 2024-2036
Figure 25: Prosthetic Heart Valves Market, United States, Volume (Units), 2024-2036
Figure 26: Surgical Heart Valves Market, United States, Company Share (%), 2025
Figure 27: Surgical Heart Valves - Pipeline Products by Stage of Development
Figure 28: Surgical Heart Valves - Pipeline Products by Segment
Figure 29: Surgical Heart Valves - Pipeline Products by Territory
Figure 30: Surgical Heart Valves - Pipeline Products by Regulatory Path
Figure 31: Surgical Heart Valves - Pipeline Products by Estimated Approval Date